ArticleAmerican journal of cancer research2023

Maintenance anlotinib improves the survival prognosis of extensive-stage small cell lung cancer: a single-arm, prospective, phase II study.

Fanming Kong et al.PubMed ↗Full text ↗

No numbers read from the abstract.